These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25712649)

  • 1. Biofunctional studies of new 2-methoxyphenylpiperazine xanthone derivatives with α₁-adrenolytic properties.
    Rapacz A; Sapa J; Nowiński L; Mogilski S; Pytka K; Filipek B; Siwek A; Szkaradek N; Marona H
    Pharmacol Rep; 2015 Apr; 67(2):267-74. PubMed ID: 25712649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hypotensive activity and alpha1-adrenoceptor antagonistic properties of some aroxyalkyl derivatives of 2-methoxyphenylpiperazine.
    Kubacka M; Mogilski S; Filipek B; Marona H
    Eur J Pharmacol; 2013 Jan; 698(1-3):335-44. PubMed ID: 23117089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buspirone functionally discriminates tissues endowed with alpha1-adrenoceptor subtypes A, B, D and L.
    Eltze M; König H; Ullrich B; Grebe T
    Eur J Pharmacol; 1999 Jul; 378(1):69-83. PubMed ID: 10478567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic, hypotensive and α1-adrenolytic properties of new 2-methoxyphenylpiperazine derivatives of xanthone.
    Rapacz A; Pytka K; Sapa J; Kubacka M; Filipek B; Szkaradek N; Marona H
    Eur J Pharmacol; 2014 Jul; 735():10-6. PubMed ID: 24751714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemically Homogenous Compounds with Antagonistic Properties at All α1-Adrenoceptor Subtypes but not β1-Adrenoceptor Attenuate Adrenaline-Induced Arrhythmia in Rats.
    Pytka K; Lustyk K; Żmudzka E; Kotańska M; Siwek A; Zygmunt M; Dziedziczak A; Śniecikowska J; Olczyk A; Gałuszka A; Śmieja J; Waszkielewicz AM; Marona H; Filipek B; Sapa J; Mogilski S
    Front Pharmacol; 2016; 7():229. PubMed ID: 27536240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential antagonism by conotoxin rho-TIA of contractions mediated by distinct alpha1-adrenoceptor subtypes in rat vas deferens, spleen and aorta.
    Lima V; Mueller A; Kamikihara SY; Raymundi V; Alewood D; Lewis RJ; Chen Z; Minneman KP; Pupo AS
    Eur J Pharmacol; 2005 Jan; 508(1-3):183-92. PubMed ID: 15680270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional and radioligand binding characterization of the α1L-adrenoceptor subtype of the human vas deferens.
    Davis BJ; Wiener M; Chapple CR; Sellers DJ; Chess-Williams R
    Auton Autacoid Pharmacol; 2015 Apr; 34(3-4):41-9. PubMed ID: 25790239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The alpha-adrenoceptor antagonist, zolertine, inhibits alpha1D- and alpha1A-adrenoceptor-mediated vasoconstriction in vitro.
    Ibarra M; Hong E; Villalobos-Molina R
    J Auton Pharmacol; 2000 Jun; 20(3):139-45. PubMed ID: 11193002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prazosin has low potency at α1A-adrenoceptors and high potency at α1D -adrenoceptors in rat vas deferens.
    Docherty JR
    Auton Autacoid Pharmacol; 2013 Oct; 33(3-4):49-57. PubMed ID: 24074250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel naftopidil derivatives containing methyl phenylacetate and their blocking effects on α
    Huang JJ; Zhang ZH; He F; Liu XW; Xu XJ; Dai LJ; Liu QM; Yuan M
    Bioorg Med Chem Lett; 2018 Feb; 28(4):547-551. PubMed ID: 29422390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, alpha-adrenoceptors affinity and alpha 1-adrenoceptor antagonistic properties of some 1,4-substituted piperazine derivatives.
    Marona H; Kubacka M; Filipek B; Siwek A; Dybała M; Szneler E; Pociecha T; Gunia A; Waszkielewicz AM
    Pharmazie; 2011 Oct; 66(10):733-9. PubMed ID: 22026152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacology of α
    Docherty JR
    Eur J Pharmacol; 2019 Jul; 855():305-320. PubMed ID: 31067439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of human alpha1-adrenoceptor subtype coupling to protein kinase C activation and related signalling pathways.
    Taguchi K; Yang M; Goepel M; Michel MC
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Feb; 357(2):100-10. PubMed ID: 9521482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of RS17053 on α
    Alsufyani HA; Docherty JR
    Fundam Clin Pharmacol; 2023 Dec; 37(6):1170-1178. PubMed ID: 37392126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of alpha1-adrenoceptor subtypes mediating contractions to phenylephrine in rat thoracic aorta, mesenteric artery and pulmonary artery.
    Hussain MB; Marshall I
    Br J Pharmacol; 1997 Nov; 122(5):849-58. PubMed ID: 9384500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affinity profile at alpha(1)- and alpha(2)-adrenoceptor subtypes and in vitro cardiovascular actions of (+)-boldine.
    Eltze M; Grebe T; Michel MC; Czyborra P; Ullrich B
    Eur J Pharmacol; 2002 May; 443(1-3):151-68. PubMed ID: 12044805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Subtype Selectivity in Search of Potent Hypotensive Agents among 5,5-Dimethylhydantoin Derived α
    Kaczor A; Knutelska J; Kucwaj-Brysz K; Zygmunt M; Żesławska E; Siwek A; Bednarski M; Podlewska S; Jastrzębska-Więsek M; Nitek W; Sapa J; Handzlik J
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nitric oxide/soluble cyclic guanylase/cyclic guanosine monophosphate pathway is involved in the cardiovascular effects of a novel α1- and β-adrenoceptor antagonist.
    Kubacka M; Mogilski S; Bednarski M; Raźny K; Sapa J; Waszkielewicz AM; Marona H; Filipek B
    Pharmacology; 2014; 94(5-6):287-95. PubMed ID: 25531925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and cardiovascular evaluation of some aminoisopropanoloxy derivatives of xanthone.
    Kubacka M; Szkaradek N; Mogilski S; Pańczyk K; Siwek A; Gryboś A; Filipek B; Żmudzki P; Marona H; Waszkielewicz AM
    Bioorg Med Chem; 2018 Jul; 26(13):3773-3784. PubMed ID: 29706529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic activity of some xanthone derivatives with β1-adrenoceptor affinities in rats.
    Rapacz A; Sapa J; Bednarski M; Filipek B; Szkaradek N; Marona H
    Eur J Pharmacol; 2014 Sep; 738():14-21. PubMed ID: 24876055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.